Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00674193 · ClinicalTrials.gov registry record
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 158
- Enrollment target
NCT00674193: Completed study, sponsored by Children's Oncology Group.
NCT00674193 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 158 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00674193 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 158 participants
- Enrollment target
Study Summary
This laboratory study is evaluating how well dactinomycin and vincristine work in treating young patients with cancer. Studying samples of blood and urine in the laboratory from patients with cancer may help doctors learn how dactinomycin and vincristine affect the body and how patients will respond to treatment.
Interventions
- OTHER laboratory biomarker analysis
- OTHER pharmacological study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2008-02 |
What the finished NCT00674193 record still lists
NCT00674193 is an observational study that tracks outcomes without assigning an intervention. The registered 158 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which laboratory biomarker analysis is the first listed.
NCT00674193 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00674193 about?
NCT00674193 is a clinical study titled "Evaluating Dactinomycin and Vincristine in Young Patients With Cancer". This laboratory study is evaluating how well dactinomycin and vincristine work in treating young patients with cancer. Studying samples of blood and urine in the laboratory from patients with cancer may help doctors learn how dactinomycin and vincristine affect the body and how patients will respond...
What is the current status of trial NCT00674193?
This trial is currently completed. The enrollment target is 158 participants. The study started on 2008-02.
What interventions are being tested in trial NCT00674193?
The interventions under investigation include: laboratory biomarker analysis (OTHER), pharmacological study (OTHER).
Who is sponsoring clinical trial NCT00674193?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486833 · 158 participants · Phase 1
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
- NCT04697966 · 158 participants · NA
Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents
- NCT04969835 · 158 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
- NCT05230732 · 158 participants · NA
Neuromodulation of Inflammation and Endothelial Function
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia